SXTP Earnings

Quarterly EPS
$-18.60
Q3 2024
$-9.10
Q4 2024
$-6.25
Q1 2025
$-5.01
Q2 2025
$-2.64
Q3 2025
$0.00
Q4 2025
$-1.28
Q1 2026
$-0.90
Q2 2026
Latest Revenue207.9K
Latest Net Income-2265586
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.90207.9K-2265586-32.5%+82.0%
Q1 2026-$1.28162.1K-2090155-36.8%+79.5%
Q4 2025316.4K-1439058+16.2%
Q3 2025-$2.64528.6K-2317036+256.9%+85.8%
Q2 2025-$5.01307.9K-1734930+144.9%+94.1%
Q1 2025-$6.25256.3K-1877301+89.4%-185.4%
Q4 2024-$9.10272.2K-2048924+537.4%+76.4%
Q3 2024-$18.60148.1K-2160498+16.8%-110.2%
Q2 2024-$84.48125.7K-4174226
Q1 2024$7.32135.3K424.1K
Q4 2023-$38.5342.7K-2046217
Q3 2023$182.60126.8K4.2M
60 Degrees Pharmaceuticals (SXTP) — Earnings